| dc.creator | Trilles, Luciana | |
| dc.creator | Fernández-Torres, Belkys | |
| dc.creator | Lazéra, Márcia dos Santos | |
| dc.creator | Wanke, Bodo | |
| dc.creator | Schubach, Armando de Oliveira | |
| dc.creator | Paes, Rodrigo de Almeida | |
| dc.creator | Inza, Isabel | |
| dc.creator | Guarro, Josep | |
| dc.date | 2019-06-13T12:44:54Z | |
| dc.date | 2019-06-13T12:44:54Z | |
| dc.date | 2005 | |
| dc.date.accessioned | 2023-09-26T23:30:03Z | |
| dc.date.available | 2023-09-26T23:30:03Z | |
| dc.identifier | TRILLES, Luciana et al. In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases. Antimicrobial Agents and Chemotherapy, v. 49, n. 9, p. 3952-3954, Sept. 2005. | |
| dc.identifier | 0066-4804 | |
| dc.identifier | https://www.arca.fiocruz.br/handle/icict/33486 | |
| dc.identifier | 10.1128/AAC.49.9.3952-3954.2005 | |
| dc.identifier | 1098-6596 | |
| dc.identifier.uri | https://repositorioslatinoamericanos.uchile.cl/handle/2250/8891236 | |
| dc.description | We have determined the antifungal susceptibilities of 34 clinical isolates of the dimorphic fungus Sporothrix
schenckii to 11 drugs using a microdilution method. In general, the type of growth phase (mycelial or yeast) and
the temperature of incubation (30 or 35°C) exerted a significant influence on the MICs. | |
| dc.description | 2019-12-13 | |
| dc.format | application/pdf | |
| dc.language | eng | |
| dc.publisher | American Society for Microbiology | |
| dc.rights | open access | |
| dc.subject | Sporothrix schenckii | |
| dc.subject | Antifungal susceptibilities | |
| dc.title | In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phases | |
| dc.type | Article | |
